Stay updated on Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial
Sign up to get notified when there's something new on the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page.

Latest updates to the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page
- Check4 days agoChange DetectedRevision history updated: added v3.5.2 and removed v3.5.0.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision history shows an addition of v3.4.3 and a deletion of v3.4.2.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision: v3.4.2 was added to the page history. The prior Notice about government funding and the Revision: v3.4.1 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check75 days agoChange DetectedA new notice about government funding status and NIH Clinical Center operations appears on the page. The page now shows Revision: v3.4.1, replacing Revision: v3.4.0.SummaryDifference0.5%

- Check82 days agoChange DetectedUI enhancements were added to the history view, including a Show glossary option and color-coded highlights for additions (green) and deletions (red). The revision label was updated to v3.4.0 and includes the No FEAR Act Data note.SummaryDifference0.6%

Stay in the know with updates to Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page.